L & S Advisors Inc raised its position in shares of CME Group Inc (NASDAQ:CME) by 124.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,888 shares of the financial services provider’s stock after buying an additional 6,042 shares during the period. L & S Advisors Inc’s holdings in CME Group were worth $2,113,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Parnassus Investments CA acquired a new stake in shares of CME Group in the second quarter valued at $544,292,000. Magellan Asset Management Ltd acquired a new stake in shares of CME Group during the second quarter worth about $418,297,000. Geode Capital Management LLC increased its position in shares of CME Group by 12.9% during the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after purchasing an additional 537,917 shares in the last quarter. Fiera Capital Corp increased its position in shares of CME Group by 17.0% during the second quarter. Fiera Capital Corp now owns 2,960,477 shares of the financial services provider’s stock worth $574,658,000 after purchasing an additional 429,235 shares in the last quarter. Finally, FMR LLC increased its position in shares of CME Group by 5.7% during the first quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after purchasing an additional 355,566 shares in the last quarter. Institutional investors and hedge funds own 84.99% of the company’s stock.

In related news, insider Sean Tully sold 7,200 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the transaction, the insider now owns 19,923 shares of the company’s stock, valued at $4,445,418.99. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $200.15, for a total value of $7,005,250.00. Following the transaction, the chief executive officer now directly owns 79,057 shares in the company, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. In the last three months, insiders have sold 59,626 shares of company stock worth $12,255,934. Corporate insiders own 1.20% of the company’s stock.

A number of analysts have recently commented on the company. Barclays lifted their target price on CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a research report on Thursday, May 23rd. Wells Fargo & Co lifted their target price on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Deutsche Bank lifted their target price on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. UBS Group lifted their target price on CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a research report on Thursday, September 5th. Finally, BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research report on Thursday. Three research analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $196.85.

Shares of NASDAQ CME traded down $0.38 during midday trading on Friday, reaching $205.00. 126,464 shares of the company were exchanged, compared to its average volume of 1,077,492. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a 1 year low of $161.05 and a 1 year high of $224.91. The stock has a fifty day simple moving average of $211.18 and a 200 day simple moving average of $191.03. The stock has a market cap of $73.56 billion, a P/E ratio of 30.06, a PEG ratio of 4.57 and a beta of 0.19.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the company posted $1.74 earnings per share. The business’s revenue was up 20.1% on a year-over-year basis. As a group, analysts forecast that CME Group Inc will post 6.69 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is currently 43.99%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: What is dividend yield?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.